medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 4

<< Back Next >>

Rev Mex Pediatr 2026; 93 (4)

Prevalence of abnormal hearing screen results at a public referral hospital in Veracruz, Mexico

Ceballos-Vela MC, Ruiz-Hernández LD, Díaz-Macedo R,Villegas-Domínguez JE, Huerta-Cortés MJ, Hernández-Rico M
Full text How to cite this article 10.35366/124157

DOI

DOI: 10.35366/124157
URL: https://dx.doi.org/10.35366/124157

Language: Spanish
References: 17
Page: 150-153
PDF size: 776.49 Kb.


Key words:

prevalence, newborn hearing screening, otoacoustic emissions, risk factors, newborn.

ABSTRACT

Introduction: early detection of hearing loss through neonatal hearing screening enables timely interventions that support language development and cognitive function. Objective: to estimate the prevalence of abnormal newborn hearing screening results at a public referral hospital. Material and methods: a descriptive, cross-sectional study was conducted by reviewing the medical records of newborns who underwent hearing screening using transientevoked otoacoustic emissions between 2022 and 2023. Results: a total of 2,731 newborns with definitive hearing screening results were included. Nineteen patients showed abnormal screening results, representing a prevalence of 0.70%. Male sex (36.8%), prematurity (21.0%), and low birth weight (5.3%) were the predominant characteristics among this group. Conclusions: the prevalence of abnormal neonatal hearing screening results at a referral hospital was 0.70%.


REFERENCES

  1. Lieu JEC, Kenna M, Anne S, Davidson L. Hearing loss in children:a review. JAMA. 2020; 324(21): 2195-2205. doi: 10.1001/jama.2020.17647.

  2. González-Jiménez B, Delgado-Mendoza E, Rojano-González Ret al. Factores para hipoacusia, tamiz auditivo neonatal. Rev MedInst Mex Seguro Soc. 2017; 55(1): 40-46. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2017/im171k.pdf

  3. Peña-Alejandro S, Contreras-Rivas Al. Prevalencia de hipoacusiaen recién nacidos sanos en un hospital de tercer nivel de atención.Detección mediante tamiz auditivo neonatal. Rev Mex Pediatr.2018; 85(4): 130-134. Disponible en: https://www.medigraphic.com/pdfs/pediat/sp-2018/sp184d.pdf

  4. Ganek HV, Madubueze A, Merritt CE, Bhutta ZA. Prevalence ofhearing loss in children living in low- and middle-income countriesover the last 10 years: a systematic review. Dev Med Child Neurol.2023; 65(5): 600-610. doi: 10.1111/dmcn.15460.

  5. Núñez-Batalla F, Jáudenes-Casaubón C, Sequí-Canet JM,Vivanco-Allende A, Zubicaray-Ugarteche J, Olleta LascarroI. Programas de cribado de la hipoacusia congénita en 2020:recomendaciones CODEPEH. Acta Otorrinolaringol Esp. 2021;72: 312-323. doi: 10.1016/j.otorri.2020.06.009

  6. Fredj S. Parental awareness and early detection of pediatrichearing loss: a clinician’s perspective on community educationstrategies. Am J Med Sci Pharm Res. 2025; 7(8): 10-12. doi:10.37547/tajmspr/Volume07Issue08-02.

  7. Joint Committee on Infant Hearing. Year 2019 position statement:principles and guidelines for early hearing detection andintervention programs. J Early Hear Detect Interv. 2019; 4(2): 1-44.

  8. Vos B, Noll D, Pigeon M, Bagatto M, Fitzpatrick EM. Risk factorsfor hearing loss in children: a systematic literature review andmeta-analysis protocol. Syst Rev. 2019; 8(1): 172. doi: 10.1186/s13643-019-1073-x.

  9. Gastelum-Gámez W, Mariscal-Marín B, Celis-Aguilar EM, Hernández-Castillo EN, de la Mora Fernández AR. Tamiz auditivo neonatal enMéxico: experiencia de un centro de atención de segundo nivel. AnOrl Mex. 2024; 69(4): 251-264. doi: 10.24245/aorl.v69i4.10033.

  10. Secretaría de Salud. NORMA Oficial Mexicana NOM-034-SSA2-2013, Para la prevención y control de los defectos alnacimiento; 2013. Disponible en: https://www.dof.gob.mx/nota_detalle.php?codigo=5349816&fecha=24/06/2014#gsc.tab=0

  11. Kostlivý T, Skopek P, Klail P, Laierová H, Skálová A, Gál B, KuceraR et al. Newborn hearing screening - an implementation analysis.In Vivo. 2024; 38(4): 1939-1946. doi: 10.21873/invivo.13650.

  12. Jeong J, Youk TM, Oh J, Eo TS, Choi HS. Neonatal and maternalrisk factors for hearing loss in children based on population-baseddata of Korea. Int J Pediatr Otorhinolaryngol. 2021; 147: 110800.doi: 10.1016/j.ijporl.2021.110800.

  13. Sabbagh S, Amiri M, Khorramizadeh M, Iranpourmobarake Z,Nickbakht M. Neonatal hearing screening: prevalence of unilateraland bilateral hearing loss and associated risk factors. Cureus.2021; 13(6): e15947. doi: 10.7759/cureus.15947.

  14. Mostafa BE, Mostafa A, Fiky LME, Omara A, Teaima A. MaternalCOVID-19 and neonatal hearing loss: a multicentric survey. EurArch Otorhinolaryngol. 2022; 279(7): 3435-3438. doi: 10.1007/s00405-021-07098-5.

  15. Eiserman W, Shisler L, Hoffman J, Foust T. Tamizaje auditivoy seguimiento en la niñez temprana: implementación de unprograma exitoso de tamizaje auditivo usando emisionesotoacústicas (OAE). Manual acompañante de los videos deinstrucción. Logan (UT): National Center for Hearing Assessmentand Management, Utah State University; 2013.

  16. Instituto Nacional de Perinatología Isidro Espinosa de los Reyes.Manual de procedimientos técnicos de la coordinación de tamizneonatal integral. Ciudad de México: Instituto Nacional dePerinatología Isidro Espinosa de los Reyes; 2026.

  17. García H. Alteraciones visuales y auditivas en prematuros. RevMex Pediatr. 2023; 90(5): 173-175. doi: 10.35366/115499




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2026;93